companydata.dkcompanydata.dk
Back to company

ELDON BIOLOGICALS A/S: Financial statements 2013

CVR: 26747007

ELDON BIOLOGICALS A/S (CVR 26747007) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 4,092,292 and a net result of DKK 948,720. Equity amounted to DKK -2,250,275.

Gross Profit
4,092,292 kr.
Profit/Loss
948,720 kr.
Equity
-2,250,275 kr.
Total Assets
4,041,325 kr.

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like ELDON BIOLOGICALS A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2013

ELDON BIOLOGICALS A/S appoints new auditorApr 26, 2013

As of April 26, 2013, V & CO STATSAUTORISERET REVISIONSANPARTSSELSKAB has been appointed auditor of ELDON BIOLOGICALS A/S.

Auditor steps down at ELDON BIOLOGICALS A/SApr 26, 2013

As of April 26, 2013, Per Sleimann Petersen has stepped down as auditor of ELDON BIOLOGICALS A/S.

About ELDON BIOLOGICALS A/S

ELDON BIOLOGICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2002. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The management consists of Kasper Juul Hedegaard. The company is owned by MEDI-TRADE ApS and HOLDINGSELSKABET MLH ApS. The company has 9 employees. In 2025, the company reported a gross profit of DKK 13,635,058 and a net result of DKK 3,900,353 compared with DKK 6,673,643 the year before. Equity amounted to DKK 42,055,949.

Other financial years

202520242023202220212020201920182017201620152014